The final stage: Investigating determinants of plasmin generation in the third trimester of pregnancy
Main Article Content
Abstract
Background. Changes in the fibrinolytic system that support haemostasis are seen in the third trimester of pregnancy. An imbalance between coagulation and fibrinolysis could increase either thrombotic episodes or haemorrhagic risk.
Objective. To assess plasma D-dimer and plasmin-a2-antiplasmin (PAP) complex levels as indication of plasmin generation during late pregnancy.
Methods. A sample of 41 healthy pregnant women in their third trimester participated in the study. Data on obstetric history, body mass index (BMI) and other demographic variables were recorded. Haematological analysis involved enzyme-linked immunosorbent assaying of venous blood samples. Statistical analysis was performed using SPSS version 21.
Results. Mean maternal and gestational age, with associated standard deviations (SD), were 30.68 (4.69) years and 34.78 (3.34) weeks, respectively. Haematological analysis showed mean (SD) values of D-dimer and PAP complex to be 194 (24 ng/mL) and 175 (11 ng/mL), respectively. Both indicators were positively correlated with maternal age, gestational age and BMI grouping, although significantly only for maternal age. Multiple linear regression analysis showed that with every increasing year of maternal age, D-dimer levels increased by 2.0 ng/mL (95% confidence interval (CI) 0.4 - 3.6 ng/mL). PAP complex levels similarly increased by 0.8 ng/mL (95% CI 0.1 - 1.5 ng/mL), after controlling for gestational age and BMI.
Conclusion. D-dimer and PAP levels increased with increasing maternal age, suggesting it to be an independent determinant of plasmin generation in the third trimester of pregnancy. If this finding is confirmed in larger studies, age should be considered when interpreting these indicator values during pregnancy.
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJOG is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
1. Hale SA, Sobel B, Benvenuto A, Schonberg A, Badger GJ, Bernstein IM. Coagulation and fibrinolytic system protein profiles in women with normal pregnancies and pregnancies complicated by hypertension. Pregnancy Hypertens 2012;2(2):152-157. https://doi.org/10.1016/j. preghy.2012.01.004
2. Xu Y, Liang Y, Parunov L, et al. Combined thrombogenic effects of vessel injury, pregnancy and procoagulant immune globulin administration in mice. Thromb J 2020;18(1):32. https://doi. org/10.1186/s12959-020-00245-8
3. O’Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol 2003;17(3):385-396.
4. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003;16(2):153- 168.
5. Aleman MM, Walton BL, Byrnes JR, Wolberg AS. Fibrinogen and red blood cells in venous thrombosis. Thromb Res 2014;133(Suppl 1):S38-40.
6. Schaller J, Gerber SS. The plasmin–antiplasmin system: Structural and functional aspects. Cell Mol Life Sci 2011;68:785–801. https://doi.org/10.1007/s00018-010-0566-5
7. Choi JW, Pai SH. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy. Ann Hematol 2002;81(11):611-615.
8. Chandra S, Tripathi AK, Mishra S, Amzarul M, Vaish AK. Physiological changes in hematological parameters during pregnancy. Indian J Hematol Blood Transfus 2012;28(3):144-146. https://doi. org/10.1007/s12288-012-0175-6
9. Han L, Liu X, Li H, et al. Blood coagulation parameters and platelet indices: Changes in normal and preeclamptic pregnancies and predictive values for preeclampsia. PLoS ONE 2014;9(12):e114488. https://doi.org/10.1371/journal.pone.0114488
10. Udomah FP, Isah IZ, Hassan M, et al. D-dimer levels among pregnant women of African descent attending antenatal clinic in a tertiary hospital in Sokoto, North Western Nigeria. Jacobs J Hematol 2015;1(1):008-015.
11. Simioni P, Campello E. Hemostatic changes in pregnancy. Rev Health Care 2013;4(3S):31-39. doi:10.7175/rhc.v4i3S.878
12. Siennicka A, Kłysz M, Chełstowski K, et al. Reference values of D-dimers and fibrinogen in the course of physiological pregnancy: The potential impact of selected risk factors – A pilot study. Biomed Res Int 2020;2020:3192350. doi:10.1155/2020/3192350
13. Uszynski M, Klyszeiko A, Zekanowka E. Plasminogen, α2-antiplasmin, and complexes of plasmin- α2-antiplasmin (PAP) in amniotic fluid and blood plasma of parturient women. Eur J Obstet Gynecol Reprod Biol 2000;93(2):167-171. doi:10.1016/S0301-2115(00)00253-4